Biden pardons Fauci, Milley and the Jan. 6 panel. It’s a guard against potential ‘revenge’ by Trump
The heads of the Jan. 6 committee say they're grateful for the decision by President Joe Biden to pardon them “not for ...
The Second Trump White House Could Drastically Reshape Infectious Disease Research. Here’s What’s At Stake.
The director of NIAID is appointed by the head of the NIH, who must be approved by the Senate. Directors have broad ...
Anthony Fauci granted preemptive pardon in the last hours of Biden’s term
In addition to Fauci, Biden also granted pardons to General Mark Milley, the Members of Congress and staff who served on the ...
NIH director to step down ahead of Trump inauguration
Director Monica Bertagnolli will resign on Jan. 17, she told staff this week, ending her tenure as the head of the $48 ...
Hosted on MSN2d
‘He’s Always Crying!’ Trump Attacks Series of Foes in Rambling Speech to Supporters
President Donald Trump took aim at a host of political rivals while promising aggressive action on January 6 prosecutions in ...
Biden pardons Fauci, Jan. 6 committee ahead of Trump inauguration
President Joe Biden granted pardons to several prominent public servants Monday who have faced attacks from President-elect ...
Science Daily20d
Officials assess threat of H5N1 avian flu
according to leading officials at the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH. In a commentary published in the New England Journal of Medicine, NIAID ...
UT scientist selected for National Inventors Hall of Fame for work on COVID, RSV vaccines
Jason McLellan, professor in the Department of Molecular Biosciences and Robert A. Welch Chair in Chemistry at UT, will be ...
The New England Journal of Medicine9mon
Interview with Dr. David Morens on the need for developing broadly protective coronavirus vaccines.
David Morens is senior advisor to the director of the National Institute of Allergy and Infectious Diseases. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal.
Nature2y
Collaborative research and licensing opportunity: Prefusion coronavirus spike proteins and their use
Inventors at the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases have developed a novel CoV S protein vaccine antigen. This technology employs protein ...